Diabetes and Cancer Connections

There is a growing body of research linking diabetes, particularly Type 2 Diabetes, with an increased risk of developing certain cancers. Chronic hyperinsulinemia and insulin resistance, common in diabetes, may promote cancer cell growth by increasing levels of insulin-like growth factors (IGFs) that encourage cell proliferation. Additionally, high blood sugar levels can contribute to inflammation and oxidative stress, both of which are factors in cancer development. Diabetic patients are at higher risk for cancers such as liver, pancreatic, colorectal, and breast cancer. Furthermore, some diabetes medications, like metformin, are being studied for their potential protective effects against cancer. Understanding the mechanisms behind the diabetes-cancer connection could lead to better prevention strategies and targeted treatments for both diseases.

    Related Conference of Diabetes and Cancer Connections

    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France

    Diabetes and Cancer Connections Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in